KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Nektar Therapeutics (NKTR) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Nektar Therapeutics (NKTR) over the last 13 years, with Q2 2022 value amounting to $187.4 million.

  • Nektar Therapeutics' Shares Outstanding rose 197.64% to $187.4 million in Q2 2022 from the same period last year, while for Jun 2022 it was $187.4 million, marking a year-over-year increase of 197.64%. This contributed to the annual value of $185.5 million for FY2021, which is 298.57% up from last year.
  • As of Q2 2022, Nektar Therapeutics' Shares Outstanding stood at $187.4 million, which was up 197.64% from $186.3 million recorded in Q1 2022.
  • Nektar Therapeutics' 5-year Shares Outstanding high stood at $187.4 million for Q2 2022, and its period low was $162.4 million during Q1 2018.
  • Moreover, its 5-year median value for Shares Outstanding was $178.3 million (2020), whereas its average is $178.3 million.
  • As far as peak fluctuations go, Nektar Therapeutics' Shares Outstanding soared by 877.99% in 2018, and later soared by 147.96% in 2019.
  • Quarter analysis of 5 years shows Nektar Therapeutics' Shares Outstanding stood at $173.5 million in 2018, then rose by 1.71% to $176.5 million in 2019, then rose by 2.03% to $180.1 million in 2020, then rose by 2.99% to $185.5 million in 2021, then rose by 1.04% to $187.4 million in 2022.
  • Its Shares Outstanding stands at $187.4 million for Q2 2022, versus $186.3 million for Q1 2022 and $185.5 million for Q4 2021.